Drug recall D-0150-2024
Product
Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India. NDC 62756-589-88
Reason for recall
Failed Impurities/Degradation Specifications
Lots and codes
Lot DND0059A Expires 12/2023 Lot DND0060A Expires 12/2023 Lot DND0061A Expires 12/2023 Lot DND0062A Expires 01/2024 Lot DND0063A Expires 01/2024 Lot DND0064A Expires 01/2024 Lot DND0065A Expires 01/2024 Lot DND0180A Expires 01/2024 Lot DND0181A Expires 01/2024 Lot DND0182A Expires 01/2024 Lot DND0183A Expires 01/2024 Lot DND0184A Expires 01/2024 Lot DND0597A Expires 02/2024
Recall details
- Recalling firm
- SUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ
- Quantity
- 96,192 bottles
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- December 4, 2023
- Terminated
- March 21, 2025
Related products
- Liothyronine Sodium – drug information
- NDC 62756-591 Liothyronine sodium · Liothyronine Sodium 50 ug/1 · Sun Pharmaceutical Industries, Inc.
- NDC 62756-589 Liothyronine sodium · Liothyronine Sodium 5 ug/1 · Sun Pharmaceutical Industries, Inc.
- NDC 62756-590 Liothyronine sodium · Liothyronine Sodium 25 ug/1 · Sun Pharmaceutical Industries, Inc.